title: A systematic investigation of the synthetic utility of glycopeptide glycosyltransferases.
abstract: Glycosyltransferases involved in the biosynthesis of bacterial secondary metabolites may be useful for the generation of sugar-modified analogues of bioactive natural products. Some glycosyltransferases have relaxed substrate specificity, and it has been assumed that promiscuity is a feature of the class. As part of a program to explore the synthetic utility of these enzymes, we have analyzed the substrate selectivity of glycosyltransferases that attach similar 2-deoxy-L-sugars to glycopeptide aglycons of the vancomycin-type, using purified enzymes and chemically synthesized TDP beta-2-deoxy-L-sugar analogues. We show that while some of these glycopeptide glycosyltransferases are promiscuous, others tolerate only minor modifications in the substrates they will handle. For example, the glycosyltransferases GtfC and GtfD, which transfer 4-epi-L-vancosamine and L-vancosamine to C-2 of the glucose unit of vancomycin pseudoaglycon and chloroorienticin B, respectively, show moderately relaxed donor substrate specificities for the glycosylation of their natural aglycons. In contrast, GtfA, a transferase attaching 4-epi-L-vancosamine to a benzylic position, only utilizes donors that are closely related to its natural TDP sugar substrate. Our data also show that the spectrum of donors utilized by a given enzyme can depend on whether the natural acceptor or an analogue is used, and that GtfD is the most versatile enzyme for the synthesis of vancomycin analogues.
authors.affiliation: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: Markus
authors.initials: M
authors.lastname: Oberthür
authors.forename: Catherine
authors.initials: C
authors.lastname: Leimkuhler
authors.forename: Ryan G
authors.initials: RG
authors.lastname: Kruger
authors.forename: Wei
authors.initials: W
authors.lastname: Lu
authors.forename: Christopher T
authors.initials: CT
authors.lastname: Walsh
authors.forename: Daniel
authors.initials: D
authors.lastname: Kahne
mesh_terms: D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000138:chemical synthesis*; D006031:Glycosylation; D016695:Glycosyltransferases / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism; D006595:Hexosamines / Q000737:chemistry / Q000378:metabolism; D007527:Isoenzymes; D007700:Kinetics; D013379:Substrate Specificity; D014640:Vancomycin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D006595:Hexosamines; D007527:Isoenzymes; C057894:chloroorienticin B; C001946:vancosamine; D014640:Vancomycin; D016695:Glycosyltransferases